Cytokine inhibitory drugs for treatment of macular degeneration

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/445 (2006.01)

Patent

CA 2543618

Methods of treating, preventing and/or managing macular degeneration are disclosed. Specific embodiments encompass the administration of a selective cytokine inhibitory drug, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.

L'invention concerne des procédés de prévention, de traitement et/ou de régulation de la dégénérescence maculaire. Dans des modes de réalisation déterminés, elle comprend l'administration d'un médicaments inhibiteur de cytokine sélective ou d'un sel pharmaceutiquement acceptable, d'un solvate, d'un hydrate, d'un stéréo-isomère, d'un clathrate, ou d'un promédicament correspondant, isolément ou en combinaison avec un deuxième agent actif et/ou en chirurgie. L'invention porte aussi sur des compositions pharmaceutiques, des formes posologiques à unités simples et des kits destinés à être utilisés dans les procédés de l'invention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cytokine inhibitory drugs for treatment of macular degeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytokine inhibitory drugs for treatment of macular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytokine inhibitory drugs for treatment of macular degeneration will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2053475

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.